Drugs / RTS,S/AS01E
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01231503 | Jan 2011 → Apr 2014 | malaria | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RTS,S/AS01E | “Subjects received 3 doses of RTS,S/AS01E (GSK257049) when ≤ 7 days of age and at 10 and 14 weeks of age.” NCT01231503 ↗ |
| Modality | Vaccine | “experimental malaria vaccine” NCT01231503 ↗ |
| Route | Intramuscular | “The RTS,S/AS01E vaccine was administered intramuscularly (IM) in the left antero-lateral thigh.” NCT01231503 ↗ |